Fraud: Why Auditing Laboratory Records Is A Bad Idea

Fraud in research has recently aroused the interest of Congress because it wastes tax dollars. But scientists share this concern for even stronger reasons: We build our whole enterprise on a foundation of communal trust. Since the record of some of our academic instituiton has been a sorry one, we should be pleased that public criticism is leading to improved procedures. If the matter had stopped there, the outcome would have been very salutary. Unfortunately, the reaction has gone much farthe

Written byBernard Davis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Unfortunately, the reaction has gone much farther. Though it is by no means clear that fraud has increased substantially in recent years, Congress has become convinced that the problem has grown rapidly and requires forceful action. Moreover, the vindictive pursuit of David Baltimore by Rep. John Dingell (D-Mich), for a case involving normal error rather than fraud, has inflamed the discussion. In this atmosphere, Congress has suggested that we need an Office of Scientific Integrity, and that it should audit laboratory records on a random basis.

Though this idea initially seemed wild to most scientists, some administrators and editors have suggested that audits are inevitable and that the scientific community should initiate them. The advantages would be forestalling an invasion by government inspectors, and replacing mere impressions of the magnitude of the problem by hard facts. However, there are good reasons for strenuously resisting this solution.

In the first place, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies